George K. Ng

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for George K. Ng

Form 4 holding Director

TuHURA Biosciences, Inc./NV

Security class
Options (Right to Buy)
Shares / value
156,240
Estimated value
$114,055
Report date
12 Feb 2026
Price
$0.7300
Ownership
Direct
Underlying class
Common Stock
Underlying amount
156,240
Form 4 holding Director

Calidi Biotherapeutics, Inc.

Security class
Common Stock
Shares / value
9,550
Estimated value
$17,190
Report date
12 Sep 2023
Price
$1.80
Ownership
By Peng Ventures, LLC
Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class
Warrants
Shares / value
43,600
Estimated value
$9,156
Report date
24 Jul 2025
Price
$0.2100
Ownership
George Ng IRRA FBO: George Ng
Underlying class
Common Stock
Underlying amount
43,600

Insider Reports Filed by George K. Ng

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .